Health & Medicine
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
Imdelltra Plus Imfinzi Cuts Risk of Death 58% in Small Cell Lung Cancer Trial
New Phase 3 data reveals that combining Imdelltra with Imfinzi slashes death risk by 58% in patients with extensive-stage small cell lung…
-
Moderna and Merck’s Personalized Melanoma Vaccine Cuts Recurrence Risk by 42% in Late-Stage Trial
By sequencing individual tumors to target unique neoantigens, Moderna’s platform creates bespoke vaccines in nine weeks, cutting melanoma recurrence risk by 42%.
-
FDA Approves At-Home Subcutaneous Skyrizi Start for Adults With Crohn’s Disease
Examining the clinical performance, mechanism, and market impact of AbbVie’s IL-23 inhibitor following its latest subcutaneous induction approval.
-
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Late-Stage Trial
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
Understanding How Novel Drug Targets Aim to Slow Alzheimer’s
Explore how emerging mid-stage research into blood-brain barriers and tau proteins shapes the future of Alzheimer’s disease drug development.
-
Sugary Drinks Linked to Higher Teen Anxiety and Depression Risk in Australian Study
A three‑year study of 6,500 Australian adolescents shows daily sugary‑drink intake increases the odds of meeting screening thresholds for depression and anxiety,…
-
How Liquid Biopsy Is Transforming Cancer Monitoring and Early Detection Strategies
Non-invasive blood tests are moving beyond niche use to become vital tools for tracking treatment response, detecting recurrence, and screening for cancer.
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
MD Anderson Reports Phase 3 Lung Cancer Immunotherapy Result and Other New Studies
New clinical findings from MD Anderson highlight advanced immunotherapy and targeted treatments, offering renewed hope for lung and prostate cancer patients.
-
New Studies Show Immunotherapy Gaining Ground in Lung, Prostate and Childhood Cancers
Researchers are moving beyond traditional toxic treatments by engineering the immune system to recognize and destroy cancer cells with greater precision.
-
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
-
The Growing Financial and Regulatory Realities of Concierge Medicine Models
As concierge practices surge in popularity, patients and providers must navigate complex Medicare rules regarding membership fees and covered services.
-
Genentech’s AL050 Deal Validates Blood-Brain Barrier Strategy
A $1.17 billion licensing agreement with Alector signals Genentech’s strategic pivot toward specialized neuro-autoimmune and rare disease biologics.
-
European Regulators Back Breakthrough Pancreatic Cancer Drug Rasonque
The EMA has recommended approval for daraxonrasib, a daily pill that doubles survival rates for patients with metastatic pancreatic adenocarcinoma.
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
How USC Scientists Are Solving the Supply Bottleneck in CAR-T Cancer Therapy
New research into lab-grown cells aims to overcome the scarcity and complexity of current CAR-T treatments, potentially expanding access for cancer patients.
-
How H. pylori’s Silent Spread Fuels 760,000 Cancers a Year—and Why Most Go Untreated
A Nobel-winning discovery linked stomach bacteria to cancer, yet antibiotic resistance and screening gaps leave millions at risk—especially in low-income nations.
-
Thyroid Eye Disease Affects 16 in 100,000 Women Yearly, Smoking Multiplies Risk
Thyroid eye disease, linked to Graves’ disease, occurs in 16 per 100,000 women annually, with smoking increasing risk nearly eightfold and severe…
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
Zanidatamab’s Dual-Targeting Design Offers Alternative To Trastuzumab Deruxtecan
Zanidatamab’s unique mechanism and clinical data show promise for HER2-positive cancer treatment
-
Google AMIE Study Shows AI Helps Doctors Prepare for Patient Visits
A large-scale study found AI chatbot summaries aided physician preparation in 75% of cases and matched final diagnoses 90% of the time.
-
NIH Funds Study On Power Outage Mortality Risks
Researchers to investigate how power outages affect survival rates for patients relying on devices like ventilators or dialysis machines
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992